Regulatory decisions diverge over aducanumab for Alzheimer's disease. Lythgoe MP, Jenei K, Prasad V. BMJ 2022;376:e069780.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lythgoe MP, Jenei K, Prasad V. Regulatory decisions diverge over aducanumab for Alzheimer's disease. BMJ 2022;376:e069780.
PMID: 35091420